[1]
R. Ravasio, A. Marcellusi, and L. De Nicola, “Economic impact of dapagliflozin in the management of chronic kidney disease in Italy: results from a micro-simulation model”, Grhta, vol. 11, no. 1, pp. 231–238, Dec. 2024.